Microba Life Sciences (FRA:F3Y) PEG Ratio: N/A (As of Jul. 09, 2026)


FRA:F3Y Microba Life Sciences Ltd FRA:F3Y
29 GF Score
Price €0.02
GF Value €0.12
! 6 Warning Signs
View Full Analysis

What is Microba Life Sciences PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Microba Life Sciences's PE Ratio without NRI is 0.00. Microba Life Sciences's 5-Year EBITDA growth rate is 0.00%. Therefore, Microba Life Sciences's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Microba Life Sciences's PEG Ratio or its related term are showing as below:



FRA:F3Y's PEG Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.345
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

Microba Life Sciences  (FRA:F3Y) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Microba Life Sciences PEG Ratio Related Terms

Microba Life Sciences PEG Ratio Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences PEG Ratio Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
PEG Ratio
0.00 0.00 0.00 0.00

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:F3Y vs TMO, DHR, IDXX: PEG Ratio Comparison

For the Diagnostics & Research subindustry, Microba Life Sciences's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences PEG Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's PEG Ratio falls into.


FRA:F3Y
29GF Score
Microba Life Sciences Ltd FRA:F3Y
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microba Life Sciences PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Microba Life Sciences's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Microba Life Sciences (FRA:F3Y) Overvalued in 2026?

Based on GuruFocus' analysis, Microba Life Sciences stock appears to be undervalued. The current stock price of €0.02 is trading 85.4% below its estimated GF Value™ of €0.12.

Key valuation signals for FRA:F3Y:

  • PEG Ratio: N/A
  • GF Value™: €0.12 vs. price of €0.02 (85.4% below fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the FRA:F3Y stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microba Life Sciences Business Description

Other Exchanges MAP:Australia
Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.
29GF Score

Get the complete analysis for FRA:F3Y

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.12
GF Value